PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 11 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Leaf extracts of C. apiculatum exhibited significant activity in more than one bioassay for anti-inflammatory, anthelmintic, anti-bilharzia, and DNA-damaging activity [PMID:11282442].
Alkaloid extracts from C. apiculatum were assessed for antimycobacterial activity to establish a rationale for traditional use in treating pneumonia and tuberculosis-associated coughs [PMID:28228097].
Evidence summary
PubMed sources
- 1.PMID: 10509422 (1999) — Use of browses (Terminalia serecia, Combretum apiculatum or Euclea schimperi) as a supplement for growing Tswana goats. · Tropical animal health and production
- 2.PMID: 28228097 (2017) — Alkaloid extracts from Combretum zeyheri inhibit the growth of Mycobacterium smegmatis. · BMC complementary and alternative medicine
- 3.PMID: 28091822 (2017) — Does the Growth Differentiation Balance Hypothesis Explain Allocation to Secondary Metabolites in Combretum apiculatum , an African Savanna Woody Species? · Journal of chemical ecology
- 4.PMID: 21621803 (2011) — Differential phenolic profiles in six African savanna woody species in relation to antiherbivore defense. · Phytochemistry
- 5.PMID: 11282442